1245.31.10117 Boehringer Ingelheim Investigational Site — Arkansas City, Kansas

1245.31.10117 Boehringer Ingelheim Investigational Site is a clinical research site located in Arkansas City, Kansas, United States.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

1245.31.10117 Boehringer Ingelheim Investigational Site has participated in 1 clinical trials.

Therapeutic areas: Diabetes Mellitus, Type 2.

Sponsors: Boehringer Ingelheim.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Arkansas City

Browse all research sites in Kansas · View every site in Arkansas City

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 1245.31.10117 Boehringer Ingelheim Investigational Site?

1245.31.10117 Boehringer Ingelheim Investigational Site has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 1245.31.10117 Boehringer Ingelheim Investigational Site conducted?

1245.31.10117 Boehringer Ingelheim Investigational Site has 1 clinical trials on record. Their work covers Diabetes Mellitus, Type 2.

Is 1245.31.10117 Boehringer Ingelheim Investigational Site accredited by Crixeo Clinical Trials?

1245.31.10117 Boehringer Ingelheim Investigational Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 1245.31.10117 Boehringer Ingelheim Investigational Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.